Medication and anti-doping: questions to ask

An athlete may need medication for mental health, pain, sleep, or another medical condition. Clinical treatment and anti-doping compliance are related but separate questions. A medicine being prescribed does not by itself establish its status under sporting rules, and a permitted status does not establish that it is appropriate treatment for a particular person.

This guide explains how to organise the right conversations. It does not clear individual medicines, provide evasion advice, or replace a prescriber or anti-doping organisation. Check the rules applicable to your sport and circumstances at the time of use.

Put medical assessment first

Tell the prescribing clinician that you participate in regulated sport and identify the relevant governing or anti-doping organisation where known. Explain your medical history, current medicines, supplements, allergies, and treatment goals honestly.

Discuss the clinical options, their potential benefits and risks, and how response will be monitored. Do not select or reject treatment from a prohibited-list search alone. The prescriber needs to assess what is medically appropriate.

Avoid stopping or changing prescribed medication solely because of a concern raised online. Contact the prescriber and the relevant anti-doping service for advice. Where a medicine has dependence or withdrawal considerations, changes may need a specific clinical plan.

Identify the rules that actually govern you

Ask which anti-doping organisation handles your circumstances and which rules apply to your competition level. Club, league, federation, and international arrangements may not be interchangeable. Do not rely on a teammate's answer without checking.

The WADA Prohibited List distinguishes substances and methods prohibited at all times, those prohibited in competition, and restrictions applying in particular sports.^[1] Read the current in-force list, not an old screenshot or a future edition that has not yet taken effect.

Confirm whether additional organisational requirements apply. A general medication database may not answer every question about a particular league, event, eligibility condition, or disciplinary process. Keep the clinical and regulatory contacts clearly identified.

Check the exact medicine and circumstances

Record the medicine's name, active ingredients, formulation, route, prescribed instructions, and country of purchase. Different products can have similar names, and a familiar brand label is not a substitute for checking the actual medicine.

Global DRO provides information about specified medicines and ingredients under the applicable WADA list within its stated coverage. Its terms explain important limitations, including that an absent result does not establish that a product is permitted.^[2]

Use official tools within their instructions and ask the relevant anti-doping organisation about unresolved details. Do not interpret a broad internet answer as individual clearance. Keep a dated record of the information and advice used.

Understand therapeutic use exemptions

A therapeutic use exemption, or TUE, is a formal process that may allow an athlete to use otherwise prohibited treatment when the applicable requirements are met. It is not automatically created by a prescription or a clinician's informal letter.^[3]

Ask which organisation should receive an application, what evidence is required, and when the process must be completed. Requirements can depend on the athlete's status and circumstances, so do not copy another athlete's application timetable.

The clinician should explain the medical rationale accurately. Administrative convenience should not lead anyone to invent a diagnosis, conceal relevant information, or claim that approval is guaranteed. An application needs the appropriate evidence and a decision from the responsible body.

Do not delay emergency treatment

Emergency medical care takes priority. Tell the treating team about your athlete status when possible, but do not postpone necessary emergency treatment while trying to resolve an online medication check.

USADA explains that emergency treatment should not be delayed and provides guidance about addressing any relevant exemption requirements afterwards.^[3] Contact the responsible organisation as soon as practical and follow its process for your circumstances.

Keep the clinical records needed to describe what happened, including treatment details and the treating service. The possibility of a retrospective process is not a blanket guarantee of approval or a reason to bypass ordinary requirements for non-emergency care.

Coordinate mental-health prescribing carefully

A mental-health treatment plan should identify the prescriber, the intended follow-up, and the route for reporting problems. Discuss how travel, sleep schedules, access to appointments, and other medicines will be managed.

Ask separately who will verify sporting status and handle any TUE documentation. A therapist, agent, or residential coordinator may support the process, but responsibilities should not remain assumed or unassigned.

Do not treat anti-doping compliance as the only measure of medication safety. The athlete and clinician still need to evaluate clinical response, adverse effects, interactions, and suitability for training or other activities. The website cannot make those decisions.

Include over-the-counter products in the discussion

Bring nonprescription medicines into the same review process. Ask about combination products, products obtained abroad, and changes suggested by another practitioner. Check the actual formulation rather than relying on the category name.

Keep an up-to-date list that can be shown to healthcare professionals. When multiple clinicians are involved, ask who reconciles the list and resolves conflicting advice. An informal group chat is not a reliable substitute for a documented medication plan.

Before a competition trip, clarify how questions about a replacement product will be handled. Do not assume that a locally purchased version has identical ingredients or the same regulatory status because its packaging looks familiar.

Treat supplements as a separate risk question

A medicine-checking database does not certify a dietary supplement. USADA states that it does not approve supplement products and explains that third-party certification may reduce, but cannot eliminate, contamination and anti-doping risks.^[4]

Discuss whether a proposed supplement has a justified role with an appropriately qualified professional. Ask about the actual product, batch, evidence, and remaining uncertainty rather than assuming that a sports label establishes safety.

Do not treat an ingredient list, marketing endorsement, or a teammate's experience as a guarantee. Keep records when a professional recommends a product, while recognising that documentation is not itself protection from every medical or regulatory problem.

Plan prescriptions and travel in advance

Ask the prescriber, pharmacy, and relevant authorities about carrying and obtaining medicines in destination and transit countries. This requires country-specific checking; anti-doping permission does not determine customs or prescribing law.

Arrange a suitable supply and documentation through legitimate channels. Discuss storage, replacement if lost, time-zone changes, and access to medical advice without making dosing changes on your own.

A residential program abroad should explain how prescribing works during the stay and after discharge. Do not assume that a foreign prescription, online consultation, or TUE automatically resolves every issue when the athlete returns home or competes elsewhere.

Maintain a clear documentation process

Choose an appropriate secure place for the current medication list, relevant clinical records, official advice, and exemption decisions. Record dates and review requirements. Limit access to people who need the information for a defined role.

Agree who will check for changes before a new season, new event, new prescription, or significant change in athlete status. Avoid assuming that last year's answer remains current indefinitely.

Where a support professional helps with administration, retain clinical accuracy and athlete involvement. The purpose is to make responsibilities visible, not to turn an agent into a prescriber or shift every compliance task onto a clinician who has not accepted that role.

Before leaving an appointment, ask the people involved to distinguish completed checks from pending decisions. Record who will follow up and how you will receive the answer. A message saying that paperwork has been submitted should not be mistaken for approval, and a confirmed sporting status should not be mistaken for a clinical instruction to start or change treatment.

A fictional example of coordinated care

An athlete receives a recommendation for treatment after a proper assessment. Before making a non-urgent change, the athlete asks the prescriber about the medical plan and asks the responsible anti-doping organisation about the exact medicine and applicable process.

The clinician supplies relevant evidence through an appropriate channel, while a coordinator helps track appointments and documents without rewriting the diagnosis. The athlete receives a clear explanation of what is confirmed and what remains pending.

This example illustrates coordination, not an assurance that a particular medicine or application will be approved. Decisions about medical need, exemption status, and return to participation remain with the appropriately responsible professionals and organisations.

Questions athletes often ask

Is a prescription enough?

Do not assume so. Prescribing establishes a clinical decision, while anti-doping status and any exemption requirements require a separate check under the applicable rules.^[3]

Can a treatment center guarantee compliance?

Ask what support it provides and what it actually verifies. No generic brochure should replace checking the precise medicine, athlete status, competition rules, and current official requirements.

Who should coordinate follow-up?

Name a prescriber and identify the relevant anti-doping contact. Include both responsibilities in the aftercare plan, together with travel arrangements, documentation, and a process for reviewing any treatment changes.